首页> 外文期刊>Archives of Oral Biology >In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains.
【24h】

In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains.

机译:细菌素PsVP-10与洗必泰和三氯生联用对变形链球菌和sobrinus链球菌菌株的体外抗菌作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To determine the minimal inhibitory concentrations (MICs) of bacteriocin PsVP-10, chlorhexidine and triclosan on S. mutans and S. sobrinus and to study the potential synergistic combination between these antimicrobial and the bacteriocin PsVP-10. DESIGN: Were determined MICs of bacteriocin PsVP-10, triclosan and chlorhexidine on strains of S. mutans and S. sobrinus, which formed a biofilm or did not form a biofilm. In addition, the synergistic effect was analysed by the determination of respective fractionary inhibitory concentrations (FICs) between bacteriocin PsVP-10 plus chlorhexidine and bacteriocin PsVP-10 plus triclosan. RESULTS: MICs of three antimicrobials used were higher in those bacterial strains, which formed a biofilm. An interesting synergistic effect on both studied species was observed when bacteriocin and chlorhexidine were combined. A slighter synergy was determined for the combination bacteriocin PsVP-10 and triclosan. CONCLUSIONS: The results showed that the combination of chlorhexidine bacteriocin PsVP-10 could reduce the number of cariogenic bacteria for in vitro studies. In the future this synergistic combination could be an alternative to antimicrobial therapy against S. mutans or S. sobrinus.
机译:目的:确定细菌素PsVP-10,洗必泰和三氯生对变形链球菌和链球菌的最小抑菌浓度(MIC),并研究这些抗菌剂与细菌素PsVP-10的潜在协同作用。设计:确定了变形链球菌和链球菌链球菌菌株的细菌素PsVP-10,三氯生和洗必泰的MIC,该菌株形成生物膜或未形成生物膜。另外,通过确定细菌素PsVP-10加洗必泰和细菌素PsVP-10加三氯生之间的各自的抑制分数浓度(FIC)来分析协同作用。结果:在那些形成生物膜的细菌菌株中,使用的三种抗微生物药物的MIC较高。当细菌素和洗必太合用时,对两个研究物种都产生了有趣的协同作用。对于细菌素PsVP-10和三氯生的组合,确定了较小的协同作用。结论:结果表明,洗必泰细菌素PsVP-10的组合可以减少致癌细菌的数量,用于体外研究。将来,这种协同作用的组合可以替代抗变形链球菌或链球菌的抗菌疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号